Multi-Site Evaluation of a Video Game for Adolescents and Young Adults With Cancer
POPULATION: Approximately 340 patients will be enrolled in this study. Patients will be 13
to 29 years of age with any cancer (original diagnosis or relapse), currently receiving
treatment and expected to be on treatment for at least 4 - 6 months following Baseline
assessment, and able to communicate effectively in English, Spanish, or French.
Approximately 170 patients will be enrolled in each of the two treatment groups. Each group
will receive either the “Re-Mission” video game and a popular interactive video game, or
just the popular interactive video game.
DESIGN: This is a multi-center, randomized trial, with patients randomized to one of two
groups. One group (50% of patients) will receive the active intervention, which is the
psycho-educational video game module called Re-Mission and a popular video game (hereafter
“RE-MISSION”) and another group (50 % of patients) will be in a game control group and
receive a popular video game only (hereafter “GAME CONTROL. The games in the RE-MISSION and
GAME CONTROL groups are delivered on identical mini, personal computers (hereafter
“Mini-PC”).
INTERVENTION: Each patient in the RE-MISSION group will be asked to play “Re-Mission” along
with the popular video game for at least one hour a week for a period of ten to fourteen
weeks. “Re-Mission” presents a 3-D environment in which the player can manipulate a
humanoid character inside the virtual body of a patient with cancer. Game-play consists of
guiding the character to destroy cancer cells and other “enemies” in the body (e.g.,
bacteria) while avoiding injury or weakness. During the process of playing the game and
guiding the character through a series of missions, the player learns about chemotherapy and
other medical treatments, health-promoting self-care behaviors, infections, and pain
management. In addition, the game has also been designed to facilitate the patient’s
ability to share knowledge and concerns with others.
DURATION OF STUDY: 9 –12 months
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Adherence
Pamela M Kato
Principal Investigator
HopeLab Foundation
United States: Institutional Review Board
HL-04-001
NCT00425139
October 2004
November 2005
Name | Location |
---|---|
Deaconess Medical Center | Spokane, Washington 99210-0248 |
Children's Hospital of Orange County | Orange, California 92668 |
Children's Mercy Hospital | Kansas City, Missouri 64108 |
All Children's Hospital | St. Petersburg, Florida 33701 |
Driscoll Children's Hospital | Corpus Christi, Texas 78466 |
Lucile Packard Children's Hospital at Stanford | Palo Alto, California 94304 |
Children's Hospital of Austin | Austin, Texas 78701 |
Children's Hospital of the King's Daughters | Norfolk, Virginia 23507 |
City of Hope National Medical Center | Los Angeles, California 91010 |
St. Joseph's Children's Hospital of Tampa | Tampa, Florida 33677-4227 |
DeVos Children's Hospital | Grand Rapids, Michigan 49503 |
Washington University | St. Louis, Missouri 63110 |
Cook Children's Medical Center | Fort Worth, Texas 76104 |
Los Angeles Children's Center for Cancer and Blood Disease | Los Angeles, California 90027 |
Children's Hospital of SW Florida / Lee Memorial Health System | Fort Myers, Florida 33908 |
Nemours Children's Clinic-Jacksonville | Jacksonville, Florida 32207 |
Kapiolani Medical Center | Honolulu, Hawaii 96826 |
LSU Children's Hospital of New Orleans | New Orleans, Louisiana 70118 |
Dana-Farber Cancer Institute and Children's Hospital | Boston, Massachusetts 02115 |
St John Van Elslander Cancer Center | Grosse Pointe Woods, Michigan 48236 |
Children's Health Care - Minneapolis | St. Paul, Minnesota 55404 |
Children's Hospital of New Mexico | Albuquerque, New Mexico 87131-0001 |
Golisano Children's Hospital, University of Rochester | Rochester, New York 14642 |
Warren Clinic / Saint Francis Hospital | Tulsa, Oklahoma 74136 |
Doernbecher Childrens Hospital - OHSU | Portland, Oregon 97239 |
Legacy Emanuel Children's Cancer Program | Portland, Oregon 97227 |
Christus Santa Rosa Children’s Hospital | San Antonio, Texas 78207 |